Stock & Company Details
AN2 Therapeutics Inc $ANTX
Price:
N/A
N/A
38M
$177M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.24
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
ANTX technical indicators
Latest AN2 Therapeutics Inc (ANTX) indicator readings as of 2026-10-09.
ANTX's 14-day RSI is 32.5, in neutral territory. At $4.40 it is trading 13.7% above its 200-day moving average of $3.87, and below its 50-day average of $5.51. Price sits below the lower Bollinger Band ($4.42 to $5.76). ADX reads 20.9, sitting between trending and range-bound.
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
Finance Bot
Ask your questions
Start by typing a question below.
